Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Antengene Corporation Limited ( (HK:6996) ) has shared an announcement.
Antengene Corporation Limited has announced its upcoming annual general meeting (AGM) to be held on June 13, 2025, both online and physically in Shanghai, China. The AGM will address several key resolutions, including the approval of the company’s financial statements for 2024, the re-election of directors, the re-appointment of Ernst & Young as auditors, and the authorization for directors to manage share allotments. These resolutions are crucial for Antengene’s governance and operational strategies, potentially impacting its market positioning and stakeholder relationships.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative oncology therapies. The company operates in the healthcare industry, emphasizing the treatment of cancer and related diseases.
YTD Price Performance: 387.50%
Technical Sentiment Signal: Sell
Current Market Cap: €214.7M
Learn more about 6996 stock on TipRanks’ Stock Analysis page.